Multidisciplinary treatment of primary orbital rhabdomyosarcoma. A single-institution experience

A. Fiorillo, R. Migliorati, M. Grimaldi, P. Vasallo, G. Canale, F. Tranfa, G. Uccello, M. Fiore, P. Muto, G. Menna, R. Parasole, G. Bonavolonta

Research output: Contribution to journalArticlepeer-review

Abstract

Orbital rhabdomyosarcoma accounts for one-fourth of the primary tumors in the head and neck region. Modern treatment modalities have led to a 2-year survival rate of about 90% in these patients. However, new therapeutic trials are designed to reduce complications and salvage more than 90% of orbital cases. Between 1979 and 1990, 12 children affected by primary orbital rhabdomyosarcoma have been diagnosed and treated at the University of Naples. Ten of them have been uniformly treated by biopsy, followed by immediate radiation and combined chemotherapy. All 12 patients are alive and free of detectable disease, from a minimum of 7 months to a maximum of 123 months after diagnosis. In all children, ocular structures have been spared and the complications observed until now have been few. The above results suggest that the association of immediate radiation therapy and chemotherapy might represent an optimal tool for treatment of orbital rhabdomyosarcoma.

Original languageEnglish
Pages (from-to)560-563
Number of pages4
JournalCancer
Volume67
Issue number3
Publication statusPublished - 1991

ASJC Scopus subject areas

  • Cancer Research
  • Oncology

Fingerprint Dive into the research topics of 'Multidisciplinary treatment of primary orbital rhabdomyosarcoma. A single-institution experience'. Together they form a unique fingerprint.

Cite this